These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1685323)

  • 1. Apomorphine--test in dystonia.
    Langkafel M; Heinz A; Schöls L; Przuntek H
    J Neural Transm Park Dis Dement Sect; 1991; 3(4):293-5. PubMed ID: 1685323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Limited value of the apomorphine test in Parkinson disease].
    Roos RA; van Laar T; van Hilten JJ
    Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1374-6. PubMed ID: 7913520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apomorphine test: evaluation of dopaminergic response in patients with Parkinson disease].
    Miranda M; Saéz D
    Rev Med Chil; 1995 Mar; 123(3):326-9. PubMed ID: 8525172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced motor complications in dopa-responsive dystonia: implications for the pathogenesis of dyskinesias and motor fluctuations.
    de la Fuente-Fernández R
    Clin Neuropharmacol; 1999; 22(4):216-9. PubMed ID: 10442251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset dopa-responsive dystonia with tremor, gait freezing and behavioural disturbance and a normal dopamine transporter scan.
    Harper A; Bayliss M; Saha R; Scutt A; Nisbet A
    Age Ageing; 2008 Nov; 37(6):719-20. PubMed ID: 18922834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult-onset dystonia: atypical manifestation of Segawa disease.
    Regula JU; Thoden U; Meinck HM
    Mov Disord; 2007 Jul; 22(9):1335-7. PubMed ID: 17516474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential response in choice reaction time following apomorphine based on prior dopaminergic treatment.
    Müller T; Benz S; Börnke C; Przuntek H
    Acta Neurol Scand; 2004 May; 109(5):348-54. PubMed ID: 15080862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine test for dopaminergic responsiveness: a dose assessment study.
    Bonuccelli U; Piccini P; Del Dotto P; Rossi G; Corsini GU; Muratorio A
    Mov Disord; 1993 Apr; 8(2):158-64. PubMed ID: 8474482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystonia: treatment with bromocriptine.
    Newman RP; LeWitt PA; Shults C; Bruno G; Foster NL; Chase TN; Calne DB
    Clin Neuropharmacol; 1985; 8(4):328-33. PubMed ID: 3907823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misdiagnoses in children with dopa-responsive dystonia.
    Jan MM
    Pediatr Neurol; 2004 Oct; 31(4):298-303. PubMed ID: 15464646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The apomorphine test in Parkinson's disease: diagnostic value].
    Linazasoro G
    Neurologia; 1993 Nov; 8(9):288-90. PubMed ID: 8297620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
    Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
    Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease.
    Chen JJ; Obering C
    Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dopa-responsive dystonia of childhood].
    Rasmussen MB; Holsteen V
    Ugeskr Laeger; 1999 Mar; 161(9):1273-4. PubMed ID: 10083825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys.
    Doan VD; Grondin R; Hadj Tahar A; Grégoire L; Bédard PJ
    Clin Neuropharmacol; 1999; 22(5):281-7. PubMed ID: 10516879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopa-responsive dystonia of childhood: a case report.
    Tan KK; Easaw PE
    Singapore Med J; 1995 Jun; 36(3):326-7. PubMed ID: 8553105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.
    Katzenschlager R; Hughes A; Evans A; Manson AJ; Hoffman M; Swinn L; Watt H; Bhatia K; Quinn N; Lees AJ
    Mov Disord; 2005 Feb; 20(2):151-7. PubMed ID: 15390035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men.
    Gontero P; D'Antonio R; Pretti G; Fontana F; Panella M; Kocjancic E; Allochis G; Frea B
    Int J Impot Res; 2005; 17(1):80-5. PubMed ID: 15510184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial.
    Vitale C; Marconi S; Di Maio L; De Michele G; Longo K; Bonavita V; Barone P
    Mov Disord; 2007 Dec; 22(16):2359-64. PubMed ID: 17894335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.